Journal of Cholesterol and Heart Disease

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Cholesterol and Heart Disease (2023) Volume 7, Issue 3

Understanding the Complex Role of High-Density Lipoprotein Cholesterol in Heart Health

Sergio Mark *

Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan

*Corresponding Author:
Sergio Mark
Department of Endocrinology and Metabolism,
Kyoto Prefectural University of Medicine,
Kyoto, Japan

Received: 29-May-2023, Manuscript No. AACHD-23-101698; Editor assigned: 01-Jun-2023, PreQC No. AACHD-23-101698 (PQ); Reviewed: 15-Jun-2023, QC No. AACHD-23-101698; Revised: 20-Jun-2023, Manuscript No. AACHD-23-101698; Published: 27-Jun-2023, DOI:10.35841/ aachd-7.3.147

Citation: Mark S. Understanding the complex role of high-density lipoprotein cholesterol in heart health. J Cholest Heart Dis 2023;7(3):147

Visit for more related articles at Journal of Cholesterol and Heart Disease




High-density lipoprotein cholesterol (HDL-C) has long been hailed as the "good" cholesterol due to its ability to remove excess low-density lipoprotein cholesterol (LDL-C) from the bloodstream. However, recent research has challenged this simplistic view, highlighting the intricate and multifaceted role that HDL-C plays in heart health. This article aims to delve into the complex relationship between HDL-C and heart disease, shedding light on its functions, mechanisms, and potential implications for cardiovascular health [1].

HDL-C, commonly referred to as the "good" cholesterol, is a lipoprotein that transports cholesterol from the peripheral tissues back to the liver for excretion or recycling. Its primary function is to facilitate reverse cholesterol transport, a process that removes excess cholesterol from cells and tissues, thereby reducing the risk of atherosclerosis, a major contributor to heart disease. HDL-C accomplishes this task by interacting with various enzymes, proteins, and receptors involved in cholesterol metabolism [2].

While the role of HDL-C in cholesterol transport is well-established, emerging evidence suggests that its cardiovascular benefits may extend beyond this traditional function. HDL-C exhibits potent anti-inflammatory, antioxidant, and antithrombotic properties, which contribute to its cardioprotective effects. It helps maintain endothelial function, prevents platelet aggregation, and inhibits the oxidation of LDL-C, all of which play crucial roles in the development and progression of cardiovascular disease [3].

Reverse cholesterol transport is a complex process involving several steps, including cholesterol efflux from cells, cholesterol esterification, and hepatic uptake. HDL-C acts as a crucial mediator of these processes, orchestrating the movement of cholesterol throughout the body. However, recent studies have questioned the correlation between HDL-C levels and cardiovascular outcomes, suggesting that HDL-C functionality, rather than its absolute concentration, may be a more significant determinant of heart health [4].

Although HDL-C is generally associated with a lower risk of heart disease, not all HDL-C particles are equally effective at promoting reverse cholesterol transport. HDL-C particles can undergo structural and compositional changes, rendering them dysfunctional and less capable of carrying out their protective functions. Factors such as inflammation, oxidative stress, and genetic variations can compromise HDL-C functionality, potentially leading to an increased risk of cardiovascular events.

The growing understanding of HDL-C's complexity has prompted researchers to explore therapeutic interventions targeting HDL functionality rather than merely focusing on HDL-C levels. Novel therapies, including HDL-mimetics and HDL-C infusion, are being investigated to enhance HDL function and potentially mitigate the risk of heart disease. However, further research is needed to fully elucidate the safety, efficacy, and long-term effects of these emerging treatment strategies [5].


High-density lipoprotein cholesterol, once considered the gold standard for assessing cardiovascular risk, is now recognized as a player in a more intricate narrative. Its role in heart health extends beyond cholesterol transport, encompassing a range of protective functions that influence vascular health, inflammation, and oxidative stress. The evolving understanding of HDL-C functionality provides valuable insights for developing targeted therapies to improve cardiovascular outcomes. As research progresses, a comprehensive understanding of the complex role of HDL-C in heart health will pave the way for more effective strategies for the prevention and treatment of heart disease.




  1. Silbernagel G, Schottker B, Appelbaum S, et al. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J. 2013;34(46):3563-71.

    Indexed at, Google Scholar, Cross Ref

  2. Mineo C, Shaul PW. Novel biological functions of high-density lipoprotein cholesterol. Circ Res. 2012;111(8):1079-90.

    Indexed at, Google Scholar, Cross Ref

  3. Pischon T, Girman CJ, Sacks FM, et sl. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circ. 2005;112(22):3375-83.

    Indexed at, Google Scholar, Cross Ref

  4. Williams PT. High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med. 1996;334(20):1298-304.

    Indexed at, Google Scholar, Cross Ref

  5. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review. Atheroscler. 2008;196(2):489-96.

    Indexed at, Google Scholar, Cross Ref

Get the App